About Focal Therapeutics
Focal Therapeutics is a Healthcare company based in Aliso Viejo (United States) founded in 2007, and was acquired by Hologic in September 2018. It develops implantable devices to assist surgeons and radiologists. Focal Therapeutics has raised $11.7 million across 3 funding rounds from investors including Hologic, Emergent Medical Partners and Okapi Venture Capital. Its focus areas include Life Sciences, Oncology, Medical Devices and Surgical Tools. Its competitors include On Target Laboratories, Averto Medical and Lumicell Diagnostics; 3 of its 3 listed competitors have raised funding.
Company details
Focal Therapeutics was founded in 2007 in Aliso Viejo, United States, within the medical device sector. Implantable devices are created by the company to support surgical and radiological tasks, with the lead product BioZorb used for marking tissue removal sites in three dimensions. This aids in treatment planning and ongoing patient care, initially applied to breast cancer cases. Operations focus on device development for clinical assistance.
- Headquarters Aliso Viejo, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website focalrx.com
- Social LinkedIn
- Acquired by Hologic (Sep 2018)
Funding Insights of Focal Therapeutics
Focal Therapeutics has successfully raised a total of $11.7M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $48.88 thousand completed in January 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $11.7M
- Total Rounds 3
- Last Round Series A — $48,880
- First Round $7.82M
(Sep 2013)
- Investors Count 2
All 3 funding rounds of Focal Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2017 | $48,880 | Series A | – | – | – |
| Mar 2016 | $3.83M | Series A | – | – | – |
| Sep 2013 | $7.82M | Series A | – | – |
3 investors in total: 3 institutional.
Investors in Focal Therapeutics
Focal Therapeutics has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Hologic, Emergent Medical Partners and Okapi Venture Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Funding and expertise are provided for medical device development. | 2017 | emvllp.com | San Jose, United States | |
US focused VC investment company | okapivc.com | Newport Beach, United States | ||
Diagnostic and surgical products for women's healthcare are provided. | 1985 | hologic.com | Marlborough, United States |
Investor details for Focal Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Focal Therapeutics
4 dated milestones of Focal Therapeutics across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Focal Therapeutics is founded.
- Funding First funding round of $7.8M.
- Funding Latest funding round, Series A, of $49K.
- Exit Acquired by Hologic.
Competitors of Focal Therapeutics
Focal Therapeutics has 3 listed competitors in our database, 3 of them funded. They include On Target Laboratories, Averto Medical and Lumicell Diagnostics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ontargetlabs.com | 2010 | West Lafayette, United States | $116.5M | 29 | Molecular imaging agents for cancer surgery are developed. | |
| avertomed.com | 2016 | Fremont, United States | $33M | 18 | Medical devices for gastrointestinal disease patients are developed. | |
| lumicell.com | 2008 | Wellesley, United States | $360.8M | 23 | Developer of fluorescence-guided imaging technologies to help surgeons detect residual cancer tissue during operations |
Detailed competitors of Focal Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Oncology
3 companies that operate in the same segment as Focal Therapeutics (Oncology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Focal Therapeutics
Focal Therapeutics was founded in 2007 and raised its 1st funding round 6 years after it was founded.
Focal Therapeutics is headquartered in Aliso Viejo, United States. It is registered at Aliso Viejo, California, United States.
Focal Therapeutics is a funded company, having raised a total of $11.7M across 3 funding rounds to date. The company's 1st funding round was a Series A of $7.82M, raised on Sep 2013.
Focal Therapeutics was founded in 2007 in Aliso Viejo, United States, within the medical device sector. Implantable devices are created by the company to support surgical and radiological tasks, with the lead product BioZorb used for marking tissue removal sites in three dimensions. This aids in treatment planning and ongoing patient care, initially applied to breast cancer cases. Operations focus on device development for clinical assistance.
Focal Therapeutics's top competitors include Lumicell Diagnostics, Averto Medical and On Target Laboratories.
Focal Therapeutics has 3 investors. Key investors include Hologic, Emergent Medical Partners, and Okapi Venture Capital.
Yes. Focal Therapeutics was acquired by Hologic in September 2018.